Lu Zou
Shanghai, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Loss of branched-chain amino acid (BCAA) metabolism mediated by IGF2BP1-LPAL2-YBX1 interaction promotes malignancy in gallbladder cancer.
Journal: Cancer letters
Published: August 05, 2025
The anticancer activity of bile acids in drug discovery and development.
Journal: Frontiers in pharmacology
Published: December 28, 2023
Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis.
Journal: Journal of translational medicine
Published: October 03, 2023
Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells.
Journal: Chinese medical journal
Published: December 16, 2022
Topological reorganization and functional alteration of distinct genomic components in gallbladder cancer.
Journal: Frontiers of medicine
Published: November 14, 2022
Case report: A de novo ERBB3 mutation develops in a gallbladder cancer patient carrying BRCA1 mutation after effective treatment with olaparib.
Journal: Frontiers in oncology
Published: October 24, 2022
Improved long-term outcomes after innovative preoperative evaluation and conception of precise surgery for gallbladder cancer.
Journal: Cancer medicine
Published: September 26, 2022
tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L.
Journal: Cellular & molecular biology letters
Published: July 09, 2022
Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathway.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: July 06, 2022
Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimen.
Journal: Hepatobiliary surgery and nutrition
Published: December 16, 2020
Last Updated: 09/26/2026